Hongxia Xu

Songtao Jiang, Yuan Wang, Sibo Song et al.

Real-world clinical decision-making requires integrating heterogeneous data, including medical text, 2D images, 3D volumes, and videos, while existing AI systems fail to unify all these signals, limiting their utility. In this paper, we introduce Hulu-Med, a transparent, generalist medical Vision-Language Model (VLM) designed to unify language-only, 2D/3D vision-language, and video understanding within a single architecture. Hulu-Med is trained on a curated corpus of 16.7 million samples, comprising exclusively public or synthetic data, spanning 12 major anatomical systems and 14 medical imaging modalities. Hulu-Med employs a medical-aware token-reduction strategy that prunes redundant visual tokens, achieving up to a 55% reduction for 3D and video inputs, improving cross-modal efficiency, and enabling training at 7B-32B parameter scales in approximately 4,000-40,000 GPU hours. Across 30 public in-domain and out-of-domain medical benchmarks-covering text reasoning, visual question answering, report generation, multilingual dialogue, video understanding, and rare disease diagnosis-Hulu-Med surpasses existing open-source models on 27 of 30 benchmarks and outperforms proprietary systems such as GPT-4o on 16 benchmarks. Despite being a VLM, Hulu-Med outperforms GPT-4o and matches GPT-o1 on the text-only HealthBench. For the first time in the community, we provide a fully transparent, reproducible and cost-effective pipeline for holistic medical vision-language understanding by releasing our end-to-end data curation, training procedures, and model parameters. Code and models are available at https://github.com/ZJUI-AI4H/Hulu-Med.

Yinlong Xu, Yanzhao Zheng, Shuoshuo Sun et al.

It has been demonstrated that carefully designed reasoning paradigms, like Chain-of-Thought (CoT) and Tree-of-Thought (ToT), can enhance the reasoning capabilities of small language models by detailed thinking and extensive thought searching, unbounded branching factors in the searching space create prohibitive reasoning consumption. However these methods fall into the trap of local optimum reasoning, which means the model lacks a global perspective while solving problems. We propose a novel reasoning paradigm called Reason from Future (RFF), which generates reasoning paths by bidirectional reasoning that combines top-down planning with bottom-up reasoning accumulation. The essence of RFF lies in its reverse reasoning mechanism, which prioritizes core logical relationships and imposes goal-oriented constraints on intermediate steps, thereby reducing the searching space and mitigating error accumulation inherent in sequential forward reasoning. Empirical evaluations across diverse experiments demonstrate that RFF outperforms conventional paradigms with higher accuracy and less searching space to solve complex tasks.

Qian Shao, Bang Du, Zepeng Li et al.

Clinical trials remain critical in cardiac drug development but face high failure rates due to efficacy limitations and safety risks, incurring substantial costs. In-silico trial methodologies, particularly generative models simulating drug-induced electrocardiogram (ECG) alterations, offer a potential solution to mitigate these challenges. While existing models show progress in ECG synthesis, their constrained fidelity and inability to characterize individual-specific pharmacological response patterns fundamentally limit clinical translatability. To address these issues, we propose a novel Drug-Aware Diffusion Model (DADM). Specifically, we construct a set of ordinary differential equations to provide external physical knowledge (EPK) of the realistic ECG morphology. The EPK is used to adaptively constrain the morphology of the generated ECGs through a dynamic cross-attention (DCA) mechanism. Furthermore, we propose an extension of ControlNet to incorporate demographic and drug data, simulating individual drug reactions. Compared to the other eight state-of-the-art (SOTA) ECG generative models: 1) Quantitative and expert evaluation demonstrate that DADM generates ECGs with superior fidelity; 2) Comparative results on two real-world databases covering 8 types of drug regimens verify that DADM can more accurately simulate drug-induced changes in ECGs, improving the accuracy by at least 5.79% and recall by 8%. In addition, the ECGs generated by DADM can also enhance model performance in downstream drug-effect classification tasks.